Alex Dmitrienko

3.7k total citations
75 papers, 2.3k citations indexed

About

Alex Dmitrienko is a scholar working on Statistics and Probability, Management Science and Operations Research and Economics and Econometrics. According to data from OpenAlex, Alex Dmitrienko has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Statistics and Probability, 26 papers in Management Science and Operations Research and 23 papers in Economics and Econometrics. Recurrent topics in Alex Dmitrienko's work include Statistical Methods in Clinical Trials (57 papers), Optimal Experimental Design Methods (26 papers) and Health Systems, Economic Evaluations, Quality of Life (22 papers). Alex Dmitrienko is often cited by papers focused on Statistical Methods in Clinical Trials (57 papers), Optimal Experimental Design Methods (26 papers) and Health Systems, Economic Evaluations, Quality of Life (22 papers). Alex Dmitrienko collaborates with scholars based in United States, Germany and United Kingdom. Alex Dmitrienko's co-authors include Ilya Lipkovich, Ajit C. Tamhane, Ralph B. D’Agostino, Benjamin James Ralph, Brian L. Wiens, Brian A. Millen, Jonathan Denne, Gregory G. Enas, Xin Wang and Christy Chuang‐Stein and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of the American Statistical Association.

In The Last Decade

Alex Dmitrienko

73 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Dmitrienko United States 27 1.3k 528 488 304 234 75 2.3k
Ying Kuen Cheung United States 28 1.1k 0.8× 595 1.1× 413 0.8× 198 0.7× 257 1.1× 114 2.5k
Paul Gallo United States 22 1.1k 0.9× 380 0.7× 489 1.0× 133 0.4× 264 1.1× 53 1.9k
Donald J. Schuirmann United States 13 1.1k 0.8× 474 0.9× 371 0.8× 221 0.7× 105 0.4× 21 2.6k
Werner Brannath Austria 35 1.7k 1.3× 1.1k 2.0× 538 1.1× 334 1.1× 91 0.4× 119 3.7k
Susan Todd United Kingdom 29 1.0k 0.8× 557 1.1× 392 0.8× 208 0.7× 110 0.5× 90 2.0k
Stephen J. Ruberg United States 21 1.0k 0.8× 333 0.6× 289 0.6× 205 0.7× 149 0.6× 75 1.8k
Dieter Hauschke Germany 26 686 0.5× 376 0.7× 213 0.4× 349 1.1× 149 0.6× 92 2.3k
Sue‐Jane Wang United States 24 1.4k 1.1× 727 1.4× 470 1.0× 270 0.9× 49 0.2× 73 1.9k
Andrew P. Grieve United Kingdom 25 780 0.6× 384 0.7× 376 0.8× 164 0.5× 337 1.4× 81 2.7k
John Whitehead United Kingdom 33 2.7k 2.0× 1.2k 2.3× 906 1.9× 379 1.2× 173 0.7× 147 4.8k

Countries citing papers authored by Alex Dmitrienko

Since Specialization
Citations

This map shows the geographic impact of Alex Dmitrienko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Dmitrienko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Dmitrienko more than expected).

Fields of papers citing papers by Alex Dmitrienko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Dmitrienko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Dmitrienko. The network helps show where Alex Dmitrienko may publish in the future.

Co-authorship network of co-authors of Alex Dmitrienko

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Dmitrienko. A scholar is included among the top collaborators of Alex Dmitrienko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Dmitrienko. Alex Dmitrienko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bunouf, Pierre, et al.. (2021). Data-Driven Subgroup Identification in Confirmatory Clinical Trials. Therapeutic Innovation & Regulatory Science. 56(1). 65–75. 3 indexed citations
2.
Bradley, Christopher, et al.. (2020). Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19. JACC. Clinical electrophysiology. 7(1). 16–25. 32 indexed citations
3.
Dmitrienko, Alex, Bodo Kirsch, Susanne Lippert, et al.. (2020). A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies. Therapeutic Innovation & Regulatory Science. 54(3). 507–518. 2 indexed citations
4.
Gráf, Alexandra, Dominic Magirr, Alex Dmitrienko, & Martin Posch. (2020). Optimized multiple testing procedures for nested sub-populations based on a continuous biomarker. Statistical Methods in Medical Research. 29(10). 2945–2957. 2 indexed citations
5.
Zink, Richard C., et al.. (2018). Rethinking the Clinically Based Thresholds of TransCelerate BioPharma for Risk-Based Monitoring. Therapeutic Innovation & Regulatory Science. 52(5). 560–571. 4 indexed citations
6.
Patra, Kaushik, Bruce Cree, Eliezer Katz, et al.. (2016). Statistical Considerations for an Adaptive Design for a Serious Rare Disease. Therapeutic Innovation & Regulatory Science. 50(3). 375–384. 2 indexed citations
7.
Dmitrienko, Alex, et al.. (2015). General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials. Journal of Biopharmaceutical Statistics. 26(1). 71–98. 28 indexed citations
8.
Dmitrienko, Alex, Gautier Paux, Erik Pulkstenis, & Jianliang Zhang. (2015). Tradeoff-based optimization criteria in clinical trials with multiple objectives and adaptive designs. Journal of Biopharmaceutical Statistics. 26(1). 120–140. 6 indexed citations
9.
Dmitrienko, Alex, Tim Friede, Alexandra Gráf, et al.. (2015). Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review. Journal of Biopharmaceutical Statistics. 26(1). 99–119. 80 indexed citations
10.
Millen, Brian A., et al.. (2014). Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference Considerations. Therapeutic Innovation & Regulatory Science. 48(4). 453–462. 5 indexed citations
11.
Dmitrienko, Alex, Brian A. Millen, Thomas Brechenmacher, & Gautier Paux. (2011). Development of gatekeeping strategies in confirmatory clinical trials. Biometrical Journal. 53(6). 875–893. 32 indexed citations
12.
Dmitrienko, Alex & Ajit C. Tamhane. (2011). Mixtures of multiple testing procedures for gatekeeping applications in clinical trials. Statistics in Medicine. 30(13). 1473–1488. 45 indexed citations
13.
Dmitrienko, Alex, Ajit C. Tamhane, & Brian L. Wiens. (2008). General Multistage Gatekeeping Procedures. Biometrical Journal. 50(5). 667–677. 96 indexed citations
14.
Agnelli, Giancarlo, Sylvia Haas, Jeffrey S. Ginsberg, et al.. (2007). A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement. Journal of Thrombosis and Haemostasis. 5(4). 746–753. 77 indexed citations
15.
Chuang‐Stein, Christy, Paul Stryszak, Alex Dmitrienko, & Walter Offen. (2006). Challenge of multiple co‐primary endpoints: a new approach. Statistics in Medicine. 26(6). 1181–1192. 52 indexed citations
16.
Dmitrienko, Alex, et al.. (2006). Gatekeeping procedures in dose–response clinical trials based on the Dunnett test. Pharmaceutical Statistics. 5(1). 19–28. 24 indexed citations
17.
Beasley, Charles M., Malcolm I. Mitchell, Alex Dmitrienko, et al.. (2005). The Combined Use of Ibutilide as an Active Control With Intensive Electrocardiographic Sampling and Signal Averaging as a Sensitive Method to Assess the Effects of Tadalafil on the Human QT Interval. Journal of the American College of Cardiology. 46(4). 678–687. 27 indexed citations
18.
Zeiher, Bernhardt, et al.. (2005). LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis*. Critical Care Medicine. 33(8). 1741–1748. 87 indexed citations
19.
Dmitrienko, Alex. (2005). Multiple Analyses in Clinical Trials: Fundamentals for Investigators. Journal of the American Statistical Association. 100(472). 1463–1463. 20 indexed citations
20.
Abraham, Edward, Venkata Bandi, Stephen F. Lowry, et al.. (2003). Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure. Critical Care Medicine. 31(3). 718–728. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Kuen Cheung Breakdown of academic impact, for papers by Paul Gallo Breakdown of academic impact, for papers by Donald J. Schuirmann Breakdown of academic impact, for papers by Werner Brannath Breakdown of academic impact, for papers by Susan Todd Breakdown of academic impact, for papers by Stephen J. Ruberg Breakdown of academic impact, for papers by Dieter Hauschke Breakdown of academic impact, for papers by Sue‐Jane Wang Breakdown of academic impact, for papers by Andrew P. Grieve Breakdown of academic impact, for papers by John Whitehead
Rankless by CCL
2026